ClinicalTrials.Veeva

Menu

Serum Ghrelin in Polycystic Ovary Syndrome

A

amr hesham el etreby

Status

Unknown

Conditions

Polycystic Ovary

Study type

Observational

Funder types

Other

Identifiers

NCT02087410
Ghrelin

Details and patient eligibility

About

measuring serum gherlin in polycystic ovary syndrome patients and compare it to healthy levels

Full description

two groups one healthy and other with pco measure ghrelin level in both of them to find relation between pco and ghrelin

Enrollment

84 estimated patients

Sex

Female

Ages

20 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:pco women

  • At least 12 months of infertility.
  • Patients with polycystic ovarian syndrome according to Rotterdam criteria:

Exclusion Criteria:

  • Patients with hyperprolactinemia
  • Patients with Cushing's syndrome
  • Patients with Congenital or non-classical adrenal hyperplasia
  • Patients with hormone secreting tumors.
  • Patients with hormonal treatment in the last 3 months.

Trial design

84 participants in 2 patient groups

study
Description:
patients with polycystic ovary syndrome
control
Description:
healthy patients serves as control group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems